Back to Search
Start Over
High-Affinity RGD-Knottin Peptide as a New Tool for Rapid Evaluation of the Binding Strength of Unlabeled RGD-Peptides to α v β 3 , α v β 5 , and α 5 β 1 Integrin Receptors.
- Source :
-
Analytical chemistry [Anal Chem] 2017 Jun 06; Vol. 89 (11), pp. 5991-5997. Date of Electronic Publication: 2017 May 24. - Publication Year :
- 2017
-
Abstract
- We describe a highly sensitive competition ELISA to measure integrin-binding of RGD-peptides in high-throughput without using cells, ECM-proteins, or antibodies. The assay measures (nonlabeled) RGD-peptides' ability to inhibit binding of a biotinylated "knottin"-RGD peptide to surface-immobilized integrins and, thus, enables quantification of the binding strength of high-, medium-, and low-affinity RGD-binders. We introduced the biotinylated knottin-RGD peptide instead of biotinylated cyclo[RGDfK] (as reported by Piras et al.), as integrin-binding was much stronger and clearly detectable for all three integrins. In order to maximize sensitivity and cost-efficiency, we first optimized several parameters, such as integrin-immobilization levels, knottin-RGD concentration, buffer compositions, type of detection tag (biotin, His- or cMyc-tag), and spacer length. We thereby identified two key factors, that is, (i) the critical spacer length (longer than Gly) and (ii) the presence of Ca <superscript>2+</superscript> and Mg <superscript>2+</superscript> in all incubation and washing buffers. Binding of knottin-RGD peptide was strongest for α <subscript>v</subscript> β <subscript>3</subscript> but also detectable for both α <subscript>v</subscript> β <subscript>5</subscript> and α <subscript>5</subscript> β <subscript>1</subscript> , while binding of biotinylated cyclo[RGDfK] was very weak and only detectable for α <subscript>v</subscript> β <subscript>3</subscript> . For assay validation, we finally determined IC <subscript>50</subscript> values for three unlabeled peptides, that is: (i) linear GRGDS, (ii) cyclo[RGDfK], and (iii) the knottin-RGD itself for binding to three different integrin receptors (α <subscript>v</subscript> β <subscript>3</subscript> , α <subscript>v</subscript> β <subscript>5</subscript> , α <subscript>5</subscript> β <subscript>1</subscript> ). Major benefits of the novel assay are (i) the extremely low consumption of integrin (50 ng/peptide), (ii) the fact that neither antibodies/ECM-proteins nor integrin-expressing cells are required for detection, and (iii) its suitability for high-throughput screening of (RGD-)peptide libraries.
- Subjects :
- Biotinylation
Cystine-Knot Miniproteins chemistry
Integrin alpha5beta1 antagonists & inhibitors
Integrin alpha5beta1 metabolism
Integrin alphaVbeta3 antagonists & inhibitors
Integrin alphaVbeta3 metabolism
Peptide Library
Peptides chemistry
Protein Binding
Receptors, Vitronectin antagonists & inhibitors
Receptors, Vitronectin metabolism
Cystine-Knot Miniproteins metabolism
High-Throughput Screening Assays
Oligopeptides
Peptides metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1520-6882
- Volume :
- 89
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Analytical chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 28492301
- Full Text :
- https://doi.org/10.1021/acs.analchem.7b00554